B-型尿钠肽对脓毒症休克危险分层的价值(2)
 |
| 第1页 |
参见附件。
[2]Lemos JA,Mc Guire DK,Drazner MH.B-type natriuretic peptide in cardiovascular disease.Lancet,2003,362(9380):316-322.
[3]Bone RC,Balk RA,Cerra FB,et al.Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis: the ACCP/SCCM Consensus Conference Committee, American College of Chest Physicians/Society of Critical Care Medicine.Chest,1992,101(6):1644-1655.
[4]American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.Crit Care Med, 1992,20(6):864-874.
[5]Elebute EA,Stoner HB.The grading of sepsis.Br J Surg,1983,70(1):29-31.
[6]Morrow DA,De Lemos JA,Blazing MA,et al.A to Z Investigators. Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease.JAMA,2005,294(22):2866-2871.
[7]Price S,Anning PB,Mitchell JA,et al. Myocardial dysfunction in sepsis: mechanisms and therapeutic implications.Eur Heart,1999,20(10):715-724.
【收稿日期】2011-04-13
(本文编辑:程旭然)
您现在查看是摘要介绍页，详见PDF附件。